Tirzepatide is a newer medication that combines both GLP-1 and GIP receptor activityoffering a dual mechanism that may lead to even greater metabolic effects
Food and Drug Administration has recently identified drug-induced alopecia (hair loss) as an adverse event for patients taking GLP-1 medications
Acetyl Hexapeptide-8 (Botox-like Peptide) Helps firm and tighten loose skin after weight loss, improving elasticity and smoothing the look of fine lines for a more toned, youthful appearance
Verma P, Kunwar A, Indira Priyadarsini K (2017) Effect of low-dose selenium supplementation on the genotoxicity, tissue injury and survival of mice exposed to acute whole-body irradiation
Debe sospecharse un cuadro de pancreatitis en pacientes con dolor abdominal intenso persistente (con o sin nuseas), y los agonistas de los receptores de GLP-1 deben suspenderse en tales pacientes
[28] it is well absorbed from the gut, and bioavailability is typically 90%